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Abstract
Background: Fibromyalgia syndrome (FMS) is a chronic condition characterized by widespread pain and associated
symptoms. We investigated cerebral activation in FMS patients by functional near-infrared spectroscopy (fNIRS).
Methods: Two stimulation paradigms were applied: a) painful pressure stimulation at the dorsal forearm; b) verbal
fluency test (VFT). We prospectively recruited 25 FMS patients, ten patients with unipolar major depression (MD)
without pain, and 35 healthy controls. All patients underwent neurological examination and all subjects were
investigated with questionnaires (pain, depression, FMS, empathy).
Results: FMS patients had lower pressure pain thresholds than patients with MD and controls (p < 0.001) and
reported higher pain intensity (p < 0.001). Upon unilateral pressure pain stimulation fNIRS recordings revealed
increased bilateral cortical activation in FMS patients compared to controls (p < 0.05). FMS patients also
displayed a stronger contralateral activity over the dorsolateral prefrontal cortex in direct comparison to
patients with MD (p < 0.05). While all three groups performed equally well in the VFT, a frontal deficit in
cortical activation was only found in patients with depression (p < 0.05). Performance and cortical activation
correlated negatively in FMS patients (p < 0.05) and positively in patients with MD (p < 0.05).
Conclusion: Our data give further evidence for altered central nervous processing in patients with FMS and
the distinction between FMS and MD.
Trial registration: ISRCTN registry ID ISRCTN15015327 (24.09.2015).
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Background
Fibromyalgia syndrome (FMS) is a chronic pain condi-
tion with a clinically well-defined presentation [1], but of
unknown etiology. FMS can be diagnosed according to
published criteria and involves chronic widespread pain
with additional symptoms like sleep disturbance or
fatigue [2, 3]; patients also often complain of cognitive
impairment. It is assumed that altered processing of
nociceptive stimuli in the central nervous system (CNS)
is involved in FMS pain. Patients with FMS have been
investigated with different radiological and nuclear medi-
cine methods for clarification of possible morphological or
functional CNS alterations compared to healthy controls
[4–7]. The current concept on the role of the CNS in
FMS pain is mainly based on the assumption of increased
central sensitization [8–10], lack of central inhibition
[11, 12], and lack of central analgesic receptors [13], while
peripheral input is also pathologically altered [14–16].
Functional near-infrared spectroscopy (fNIRS) is an
easily applicable imaging technique that has no known
side effects. fNIRS allows the investigation of cerebral
activity as a function of cortical concentration changes
of oxygenated and deoxygenated hemoglobin. Based on
data from functional magnetic resonance imaging (fMRI)
studies [17], we hypothesized that pain associated cor-
tical activation in FMS patients is stronger and has a
wider spatial distribution compared to controls that can
be detected with fNIRS. To test this hypothesis we per-
formed fNIRS under painful stimulation in groups of
* Correspondence: ueceyler_n@ukw.de
†Equal contributors
1Department of Neurology, University of Würzburg, Josef-Schneider-Str. 11,
Würzburg 97080, Germany
Full list of author information is available at the end of the article
© 2015 Üçeyler et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Üçeyler et al. BMC Neurology  (2015) 15:210 
DOI 10.1186/s12883-015-0472-4
patients with FMS, unipolar major depression (MD)
without pain, and healthy controls. Since cognitive
impairment is frequently reported by FMS patients and
supporting findings have been reported [18] we add-
itionally performed fNIRS under cognitive stimulation.
Methods
Subjects
Our study was approved by the Würzburg Medical
School Ethics Committee and written informed consent
was obtained from all study subjects prior to inclusion.
We included 25 FMS patients (23 women and two men)
diagnosed according to the 1990 criteria of the American
College of Rheumatology (ACR) [3]. Patients were re-
cruited from all over Germany between 2007 and 2012
(Additional file 2: Figure S1). Inclusion criteria were: male
and female patients ≥18 years; other possible differential
diagnoses excluded (e.g. rheumatologic, orthopedic); no
clinically relevant psychiatric disorder (examined by sys-
tematic psychiatric interview); willingness to participate in
all tests during the study. The following exclusion criteria
were applied: pain of other origin (e.g. rheumatoid arth-
ritis; post-surgery pain); current or prior cerebral disease
(e.g. stroke, cerebral hemorrhage, head trauma). The me-
dian age of the FMS patients was 59 years (range 50–70
years). All patients were examined at the Department
of Neurology at the University Hospital of Würzburg,
Germany.
We also investigated a group of ten patients (nine
women, one man; n = 7: in-patients, n = 3: out-patients)
with unipolar major depression (MD) without pain his-
tory as disease controls. We included this group to con-
trol for possible confounding effects of depression on
the study results, because depressive symptoms are fre-
quently observed in FMS patients. Patients were re-
cruited at the Department of Psychiatry at the University
Hospital of Würzburg between 2010 and 2011. The diag-
nosis was made by two trained psychiatrists according to
the ICD-10 DCR (Diagnostic Criteria for Research; http://
www.who.int/classifications/icd/en/GRNBOOK.pdf). All
patients suffered from recurrent depressive episodes. The
median age of the patients with MD was 50 years (range
39–75). Patients were not included in the following
cases: pain of any source; psychiatric comorbidities
(bipolar-affective disorder, schizophrenia, anxiety dis-
order, obsessive-compulsive disorder, eating disorder
or substance abuse); current or prior cerebral diseases
(e.g. stroke, cerebral hemorrhage, head trauma).
The control group consisted of 35 healthy volunteers
(31 women, 4 men). Subjects were interviewed to ex-
clude comorbidities like pain, depression and other psy-
chiatric disorders, or cerebral disorders. The control
group was matched with the FMS patient group as for
age, gender, and educational background. The median
age was 59 years (range 29–70). Data on the peripheral
nervous system of our patients have been published re-
cently [15]. All study participants were right-handed.
Additional file 1: Table S1 gives further details on the
patient groups.
Clinical examination and questionnaire assessment
All patients were investigated neurologically by the same
investigator and the diagnosis of FMS was confirmed.
For pain characterization we applied the German version
of the Graded Chronic Pain Scale (GCPS) [19]. From the
GCPS we used the mean value of the three pain intensity
items as an indicator of pain severity, and the mean
value of the three items rating pain interference with so-
cial, occupational, and recreational activities as a disabil-
ity score. To assess depressive symptoms the validated
German version of the Beck Depression Inventory II
(BDI) was applied scanning the last two weeks [20]. The
calculated scores translate to >14 mild, >20 medium,
>29 severe depression. The German version of the Fibro-
myalgia Impact Questionnaire (FIQ) was used to deter-
mine FMS associated symptoms, daily impairment, and
overall well-being in the last week [21]. The FIQ was
used instead of the revised FIQ, which was published
after study initiation. A maximum FIQ score of 80 can
be reached. All study participants were also assessed
with the German “Saarbrücker Persönlichkeitsfragebo-
gen” (SPF) (http://psydok.sulb.uni-saarland.de/volltexte/
2009/2363/) that is based on the Interpersonal Reactivity
Index (IRI) [22]. This multidimensional questionnaire
tests for different components of empathy and contains
one cognitive (perspective taking) and three emotional di-
mensions (fantasy, personal distress, empathic concern).
Functional NIRS recordings (fNIRS)
Data acquisition
We investigated cortical activation of the study partici-
pants with fNIRS during two tasks:
1) Muscular pressure pain: fNIRS measurements were
performed during the application of painful pressure
on the muscle bulk of the finger extensors of the
dominant hand side (which was the right side in all
cases) using a calibrated algesiometer (Wagner
Instruments, USA; Additional file 3: Figure S2). For
this stimulation we first determined the individual
pressure pain threshold by applying increasing
pressure with the algesiometer until the study
participant reported pain. Pain intensity at the
individual pain threshold was rated on a numeric
rating scale (NRS) with zero (no pain at all) to 100
(worst pain imaginable). Having identified individual
pressure pain thresholds, we could then calibrate
pressure stimulation to apply either painful
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(5 N above the threshold) or non-painful (5 N below
the threshold) pressure. A total of 20 painful and 20
painless stimuli were applied in a randomized
order. For computer aided randomization we used
Presentation Software (Neurobehavioral Systems
Incorporation, USA) so that the stimulus to be
applied (painful or painless) was presented to the
investigator on a monitor. The stimulation conditions
were as follows: pressure application for two seconds;
pause for ten seconds between two stimuli to allow
hemodynamic response to return to baseline; no two
stimulations at the same location. Additionally, we in-
vestigated ten randomly chosen FMS patients and
matched healthy controls with a control condition:
FMS patients and healthy controls were stimulated
with a pressure intensity just at the median pain
threshold of FMS patients, which was rated
non-painful by healthy controls. Otherwise, the
same procedure as described above was used. This
experiment was included to investigate the extent
of cortical activation when both study groups
were stimulated with the same pressure intensity
which was painful for FMS patients but painless
for healthy controls.
2) Verbal fluency test (VFT): The VFT paradigm
consisted of three conditions. Subjects were asked to
produce as many different nouns as possible a)
starting with a certain letter (A, F, and S), or b)
belonging to the same category (animals, fruits, and
flowers) or c) to name the days of the week as a
control condition. Each condition lasted for 30 sec
followed by 30 sec rest. Subjects worked on nine
blocks in total (3 × letters, 3 × categories, 3 × week
days). The VFT paradigm was used for two reasons:
i) it reliably activates the frontal cortex and was thus
an internal control, ii) FMS patients often complain
of difficulties in word finding [23].
Data assessment
Concerning fNIRS data we assessed the difference in
O2Hb levels comparing recordings between baseline and
post-stimulation periods. Previous studies showed that
O2Hb is more sensitive to regional changes in cerebral
blood flow than HHb [24, 25], and that cranial and cuta-
neous circulation does not change main fNIRS results
[26]. During fNIRS recordings a moving average of 5 sec
and a high pass filter were applied using the imple-
mented ETG-4000 software. After data export fNIRS
records for local pressure pain stimulation were analyzed
with a model based approach for event related study de-
signs [27]. First, data underwent a low pass filter and a
discrete cosine filter. In the next step, a hemodynamic
response function (hrf ) was constructed for every stimu-
lus. With a peak time of 6.5 sec and a Gaussian shape it
represented the expected hemodynamic response after
every stimulus and served as a predictor in the next step
of the analysis. Using a general linear model as an estab-
lished model in fNIRS and also in fMRI studies [28] beta
weights were estimated for each stimulus based on the
modeled hrf and averaged for every condition and every
channel in each subject. Data of VFT (block design)
were averaged for the nine task periods (30 sec) with an
onset delay of 3 sec, a trial length of 27 sec, and a base-
line starting 3 sec before the onset of the task for each
channel in every subject. Afterwards data were averaged
for the three conditions. The onset delay was used to
make sure to process only fNIRS data during the VFT
task as it took subjects sometimes one or two seconds to
start the task after the prompt. Both tasks activate the
DLPFC, which is the interface between the pain neuro-
matrix and the neuronal network of cognitive functions
[29]. Task 1) and 2) were applied in randomized order.
Study subjects were seated in a quiet and dark room in
front of a monitor and a keyboard; they were instructed
to relax, avoid movements, and close their eyes. Cerebral
activation leads to an initial drop in local oxygenated
haemoglobin (O2Hb) levels followed by a compensatory
hyperperfusion and oxygenation of the active brain area
[30]. This secondary rise in local oxygen levels is re-
corded via fNIRS as a function of increased brain activ-
ity. We used a continuous wave NIRS device (ETG-4000
Optical Topography System; Hitachi Medical Corpor-
ation, Tokyo, Japan) that emits light at wave lengths of
695 ± 20 nm and 830 ± 20 nm and has a temporal
resolution of 10 Hz. Two 3x5 probe sets of optodes
(8 emittors, 7 detectors; Additional file 4: Figure S3)
forming 22 channels were placed bilaterally over the
dorsolateral prefrontal cortex (DLPFC) and the pri-
mary and secondary somatosensory cortex. For all
channels, the emitter-detector separation was 3 cm,
which translates to a spatial resolution of 0.5–2 cm
depth [31, 32]. The second-last optode of each probe
set was placed over the electrode positions T3 and
T4 (detectors) respectively according to the inter-
national 10–20 system (Additional file 4: FigureS3).
The anatomical correlates were determined according
to Okamoto et al. [33].
Number connection test
To differentiate between potential executive dysfunction
and generalized cognitive impairment particularly in
low-performing patients in the VFT, we applied the
German “Zahlenverbindungstest”, which is a simple
number connection test (NCT) [34]. The NCT is a sim-
ple tool for testing cognitive speed and performance that
is frequently reported to be reduced in FMS patients.
Each study participant was presented four sheets with
randomly written numbers from zero to 90 and was
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asked to connect these numbers in ascending order by
drawing a line between. The time needed for completing
the task was determined.
Statistical analysis
We used MATLAB 7 (The MathWorks, Ismaning,
Germany) and the IBM PASW Statistics 19.0 soft-
ware (Munich, Germany) for statistical analysis. The
Kruskal-Wallis test was applied for data comparison
of non-normally distributed data; these data were il-
lustrated as boxplots giving the median, the upper
75 % and lower 25 % percentiles and the minimum
and maximum values. For correlation analyses in
normally distributed data we used the bivariate Pear-
son correlation. P < 0.05 was assumed significant. For
statistical analysis of fNIRS data 2 × 3 ANOVAs for
repeated measures were conducted for the pressure
pain stimulation comprising the factors “condition”
(painful stimulation and non-painful stimulation) and
“group” (FMS patients, patients with depression, and
healthy controls). To analyze the VFT paradigm 3 × 3
ANOVAs were calculated containing the factors
“condition” (letter version, category version, and
weekdays) and “group” (FMS patients, patients with
MD, and healthy controls). Blocks within each con-
dition were averaged for each channel. ANOVAs
were conducted separately for each channel. Post-hoc
comparisons used t-tests for dependent and independent
samples as appropriate. The modified Bonferroni adjust-
ment according to Dubey and Armitage-Parmar was used
to correct for multiple testing [35]. This method considers
the high spatial correlation between NIRS channels and
has been used in numerous publications (e.g. [36, 37]).
Corrected alpha-levels and critical t-values for each com-
parison are listed in every legend as well as the spatial cor-
relation (Pearson).
Results
Clinical findings
Neurological examination was normal in all patients.
There was no significant difference in demographics be-
tween the groups.
Pain intensity and impairment due to pain was
higher in FMS patients compared to patients with de-
pression and to healthy controls (Additional file 5:
Figure S4A-C, p < 0.001 each), while FMS patients
and patients with MD did not differ in depressive
symptoms (Additional file 5: Figure S4D). FMS pa-
tients reached higher scores in the FIQ compared to
patients with MD (p < 0.01) and to controls (p < 0.001;
Additional file 5: Figure S4E). In the SPF patients
with FMS showed higher scores for personal distress
(p < 0.01) and empathic concern (p < 0.05) compared
to healthy controls.
Patients with FMS have lower pressure pain thresholds
and report on higher pain intensities
FMS patients had the lowest median pressure pain
thresholds (16, 13–27 N) compared to patients with
depression (35, 25–55 N) and healthy controls (38,
25–60 N, p < 0.001 each). Interestingly, subjective me-
dian pain intensity at the threshold pressure was
higher in FMS patients (72, 52–88 NRS) than in con-
trols (54, 34–85, p < 0.05). The pain threshold and the
beta weight difference between the painful and the
non-painful stimulation during the fNIRS measurement
did not correlate in any of the groups (r < ±0.344,
p > 0.05).
FMS patients show bilateral cerebral activation upon
unilateral painful stimulation
Assessment of fNIRS data for the three groups (FMS
patients, MD patients and healthy controls) revealed a
significant main effect “condition” for channels 3, 6, 7,
20, and 21 of the probe set placed over the left hemi-
sphere (10.5 > F(1.57) >4.24, p < 0.05) and a significant
interaction “group x condition” in channels 6, 7, and 22
on the left and in channel 1 on the right hemisphere
probe set (5.44 > F(2.57) >3.24, p < 0.05). Regardless of the
group all subjects showed a stronger increase of [O2Hb]
in the control condition in channels 3, 6, and 7 and a
stronger increase during the pain condition in channels
20 and 21. Post-hoc comparisons between conditions for
the seven significant channels showed a stronger in-
crease in [O2Hb] for the painful stimulation of FMS pa-
tients in channels 20, 21, and 22 over the left and in
channel 1 over the right hemisphere (t(24) > 2.0, p < 0.05).
Channels with significant differences were located over
the DLPFC and primary and secondary somatosensory
cortices (Fig. 1). Healthy controls showed greater activity
only in channel 20 on the left hemisphere. Patients with
MD displayed no differences in activation between the
conditions. After correcting for multiple testing only
channel 20 in FMS patients remained significant (Fig. 1).
The direct comparison of the cerebral activation in pa-
tients with FMS and patients with MD in the seven sig-
nificant channels revealed that FMS patients had a
higher activation in four channels over the left (3, 6, 7,
and 22) and in channel one over the right hemisphere
(t(33) > 2.71, p < 0.01; Fig. 2A). When comparing FMS pa-
tients and controls directly the group differences did not
reach statistical significance.
At-threshold pain stimulation induces cerebral activation
only in FMS patients
As described above an additional control condition was
applied to ten randomly chosen FMS patients and ten
matched controls. Subjects were stimulated with a pres-
sure intensity of 15 N that was the median value of the
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pain threshold of FMS patients but painless for healthy
controls. Under this condition an ANOVA displayed a
main effect of “group” in four channels over the left
hemisphere (1, 5, 6, 7) and in channel 6 over the
right hemisphere (4.7 < F(1,18) < 8.7, p < 0.05) and an
interaction “group × condition” in ten channels on
the left (9, 13, 14, 16, 17, 18, 19, 20, 21 and 22) and
three channels on the right side of the probe set (19,
20 and 21; 4.7 < F(1,18) < 9.0, p < 0.05). Regardless of
the nature of the stimulus FMS patients showed less
changes in [O2Hb] in five channels (1, 5, 6, 7 on the
left and 6 on the right side). Corrected post hoc t-
tests for the interaction “group × condition” revealed
a stronger increase in [O2Hb] for the pain stimulus
in contrast to the painless stimulus for FMS patients
then in healthy controls in channels 14, 20, 21, and
22 on the left side and in channel 19 on the right
side of the probe set (t(33) > 2.7, p < 0.01; Fig. 2B).
FMS patients thus showed a clearly more pronounced
cerebral activation in response to the painful stimulus
also in channels covering the DLPFC.
Cognitive performance is not different between FMS
patients and controls, while prefrontal activation is
distinct between patients with FMS and depression
Patients with FMS performed as well as patients with
depression or healthy controls in the VFT (1.61 < F(2.59)
< 2.21, 0.12 < p < 0.22) and in the NCT. For the fNIRS
data ANOVAs showed a significant main effect “condi-
tion” for all channels (F(2.114) >5.0, p < 0.01) and an inter-
action “groups × condition” for nine channels on the left
and three channels on the right side of the probe set
(F(4.114) > 2.5, p < 0.05). All subjects displayed a stronger
increase in [O2Hb] during the letter condition as com-
pared to the weekday condition (t(59) > 3.75, p < 0.001).
The same was observed for the category versus the
Painful vs painless pressure stimulation
FMS
N = 25
Controls
N = 25
Depression
N = 10
Fig. 1 Cerebral activity in fNIRS recordings after painful versus painless pressure stimulation. Coloured circles present the results of t-tests comparing
the beta weights between two conditions (painful versus painless stimulation) for each of the three study groups for significant channels. Each circle
shows the t-value of the comparison in each channel (indicated by the colour bar, where dark red represents the largest t-value [+3] and dark blue the
smallest t-value [0]). Data from the contralateral hemisphere are presented in the left column while those from the ipsilateral hemisphere are presented
in the right column. The channel marked with a red circle withstands the DAP correction for multiple testing (left side r59 = 0.441, critical t-value
(two-sided) = 2.69, α = 0.009; right side r59 = 0.455, critical t-value (two-sided) =2.67, α = 0.01)
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weekday condition (t(59) 2.76, p < 0.01) except for
channel 9 on the right side where no significant dif-
ference could be found (t(59) = 0.39, p = 0.70). For the
greater part of the probe set the increase in oxygen-
ated hemoglobin during the letter condition exceeded
the category condition (t(59) > 2.15, p < 0.05). Only
channels 16, 18, 19, 20, and 21 on the right and
channels 14, 19, 20, 21, and 22 on the left side
showed no difference between the conditions (t(59) < 1.93,
p > 0.05). While fNIRS measurements showed no dif-
ference in cortical activation during the VFT between
patients with FMS and healthy controls, patients with
MD displayed a frontal deficit of cortical activation.
They showed a smaller increase in [O2Hb] (corrected
for the weekday task) as compared to FMS patients
during the letter condition (left side channels 6, 7, 11,
12, 15, 16, and 22; t(33) >2.66, p < 0.01; right side
channels 3 and 13; t(33) > 2.64, p < 0.01). During the
category task only channel 22 on the left side showed
a significant difference between patients with MD and
with FMS (t(33) = 2.93, p < 0.01). The same was ob-
served when comparing MD patients and controls
(letter condition: left side channels 2 ,3, 6, 7, 8, 11,
12, 14, 15, and 16; t(33) > 2.66, p < 0.01; right side
channels 2, 3, 4, and 18; t(33) > 2.64, p < 0.01; category
condition: left side channels 12, 15, and 22; t(33) >
2.75, p < 0.01; right side channel 22; t(33) = 3.18, p < 0.01).
The frontal deficit displayed by MD patients in compari-
son to healthy controls during the VFT was described pre-
viously [38] (Fig. 3).
a
b
Painful vs painless pressure stimulation
FMS (N = 25) vs Depression (N = 10)
FMS (N = 10) vs additional Controls (N = 10)
Fig. 2 Cerebral activity in fNIRS recordings after painful pressure stimulation comparing FMS patients with patients with depression and with
healthy controls. a Coloured circles present the results of DAP corrected post-hoc t-tests comparing the beta weights between two conditions
(painful versus painless stimulation) for the comparisons between patients with fibromyalgia syndrome (FMS) and depression (left side r59 = .441,
critical t-value (two-sided) =2.69, α = 0.009; right side r59 = 0.455, critical t-value (two-sided) = 2.67, α = 0.01). Each circle shows the t-value of the
respective comparison in each channel (indicated by the colour bar, where dark red represents the largest t-value [+3] and dark blue the smallest
t-value [−3]). Data from the contralateral hemisphere are presented on the left side while those from the ipsilateral hemisphere are presented on
the right side. Painful pressure stimulation leads to a much stronger cerebral activation in FMS patients than in patients with depression. b Coloured
circles present the results of DAP corrected post-hoc t-tests comparing the beta weights between two conditions (stimulation with a pressure intensity
just at the pain threshold of FMS patients, i.e. painless for healthy controls) for the comparisons between patients with fibromyalgia syndrome (FMS)
and healthy controls for significant channels (left side r59 = 0.441, critical t-value (two-sided) = 2.69, α = 0.009; right side r59 = 0.455, critical t-value
(two-sided) = 2.67, α = 0.01). Each circle shows the t-value of the respective comparison in each channel (indicated by the colour bar, where dark red
represents the largest t-value [+3] and dark blue the smallest t-value [−3]). Data from the contralateral hemisphere are presented on the left side while
those from the ipsilateral hemisphere are presented on the right side. The stimulation leads to a bilateral cerebral activation only in FMS patients
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FMS patients with lower cortical activation perform better
in the VFT than those with high cortical activation
For the category task of the VFT no correlation was
found between performance and cortical activity in any
of the three study groups. In the letter task however,
FMS patients showed a negative correlation between
performance and cortical activity as measured with
fNIRS. FMS patients producing a higher number of cor-
rect words displayed lower task related cortical activa-
tion (Additional file 5: Figure S4). Correlations reached
significance in channels 10, 14, 15, 20, and 21 over the
left and in channels 11, 13, 17, 18, 19, and 21 over the
right hemisphere (r > −0.40, p < 0.05; Additional file 5:
Figure S4). In contrast, patients with MD showed a posi-
tive correlation between the number of correct words
beginning with a certain letter and oxygenation changes:
cortical activity was increased in channels 1, 8, and 10
over the left and in channels 1, 2, 7, and 11 over the right
hemisphere (r > 0.65, p < 0.05). Patients with MD produ-
cing a higher number of correct answers showed greater
cortical activation in temporo-frontal areas (Additional file
6: Figure S6). In controls no such correlation was found
and also no correlation was found for the weekday task.
Discussion
This is the first report on bilateral cerebral activation
following unilateral painful stimulation in patients with
FMS as measured by fNIRS. Our study adds to the
growing evidence of an augmented cerebral activation
upon painful stimulation as one contributor to pain in
FMS. Additionally, clear differences in cortical activation
during a cognitive task could be observed between pa-
tients suffering from FMS and MD.
FMS
N = 25
Controls
N = 25
Depression
N = 10
Fig. 3 Cerebral activity in fNIRS recordings during the verbal fluency test. Coloured circles present the results of DAP corrected t-tests comparing
the beta weights between two conditions for each of the three study groups during the verbal fluency test (VFT); left side r59 = 0.467, critical
t-value (two-sided) = 2.66, α = 0.01; right side r59 = 0.48, critical t-value (two-sided) = 2.64, α = 0.01). Each circle shows the t-value of the comparison
in each channel (indicated by the colour bar, where dark red represents the largest t-value [+8] and dark blue the smallest t-value [0]). Data from
the contralateral hemisphere are presented in the left column while those from the ipsilateral hemisphere are presented in the right column.
Patients with FMS did not differ in cerebral activation, while patients with depression showed a reduction of frontal cerebral activation
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Our data are in line with the results of fMRI studies in
FMS patients where painful stimulation with identical
stimulus intensities led to an augmented cerebral activa-
tion of pain-related brain areas of FMS patients com-
pared to healthy controls [5, 17, 39]. The investigation of
the DLPFC as an important part of the descending pain
modulatory system is of major interest [40]. Mere antici-
pation of pain already elicited greater DLPFC activation
in FMS patients as compared to healthy controls [41]. In
a recent study using 2D-chemical shift imaging MR-
spectroscopy sequences, the choline/creatine variability
in the right DLPFC was different between FMS patients
and healthy controls and correlated with pain in FMS
patients [7]. Also, we confirm the augmented cerebral
activation in FMS patients at pressure levels that are not
painful for controls [17]. Similarly, FMS patients dis-
played a bilateral and stronger cerebral activation upon
thermal stimulation while controls only showed a
contralateral activation [42]. Our data also confirm pre-
vious findings that patients with FMS have lower pres-
sure pain thresholds compared to controls and rate
higher pain intensities upon identical stimulus intensity.
fNIRS is an imaging technique that has only been ap-
plied in few pain studies so far. Since no side effects are
known NIRS has mostly been used in newborns and
children (e.g. [43]. In one study the temporal and spatial
characteristics of somatosensory cortex activation was
investigated; NIRS differentiated between mechanically
painful and non-painful stimuli [44]. In another study a
correlation was found between fNIRS signals and pa-
tients’ subjective acute pain levels [45]. NIRS was also
used to visualize pain during painful procedures like in
cardiac surgery [46] or arthroscopic shoulder surgery
[47] and in migraineurs [48]. In a recent study fNIRS
was applied in rats to study the changes in blood
hemoglobin levels during painful and non-painful stimu-
lation [49].
Our study contributes to the ongoing debate on
whether FMS is an independent entity or a variant of de-
pression. Here we provide further evidence for a distinct
pathophysiology of FMS compared to MD. We show
that FMS patients differ in their cortical activity from
patients with MD but without pain by a) stronger and
bilateral cortical activation upon painful stimulation, b)
normal cortical activation during executive functions
(VFT), and c) a higher cortical activation during the let-
ter task of the VFT correlating with low performance.
The prefrontal cortex plays a crucial role in executive
functioning [50]. Similar to patients with depression,
FMS patients usually perform worse on tests targeting
working memory, executive control, and attention [51, 52].
Distinct from patients with FMS, patients suffering from
depression showed a lower cortical activation during the
VFT which lines up with previous findings [38]. The VFT
is a well-established paradigm for the investigation of ex-
ecutive frontal brain functioning [53] and reliably elicits
DLPFC activation [54]. As shown before we did not find a
difference in the VFT when comparing the performance of
FMS patients with age-matched healthy controls [55]. We
also did not find indications of cognitive impairment or re-
duced mental performance although patients subjectively
report on such symptoms as previously described [56].
However, one striking finding of our study is that increased
cortical activation in FMS patients correlated negatively
with performance in the letter task of the VFT, while in
patients with MD higher cortical activity correlated with
better performance. Together with the augmented cortical
activation upon low grade pressure pain stimulation ob-
served in FMS patients this phenomenon might be due to
a predisposition for over-activation of the nervous system.
Our study has several limitations. Our group of
patients with FMS is relatively small, which might be the
reason for the lack of correlation between pain inten-
sities or thresholds compared to cortical activity as mea-
sured by fNIRS. Also, the group of patients with MD is
small and we have not investigated a group of patients
with concomitant depression and pain. This was due to
the low mental and physical endurance of these severely
affected patients who disagreed to participate in such a
tedious study with several different tasks. Furthermore,
NIRS only reaches superficial and selected brain areas.
However, in accordance with previous data [54, 57], our
results show that reliable and reproducible fNIRS re-
cordings can be obtained with the paradigms used and
the findings line up well with previous data of fMRI
studies. Investigations so far revealed no evidence for
a substantial influence of fNIRS recordings by non-
neuronal confounders like extra-cerebral circulation
or muscle activity [26].
The advantages of NIRS as compared to MRI out-
weigh the limitations for studies examining FMS pa-
tients: NIRS is easy to perform and convenient for the
patient; NIRS has almost no exclusion criteria and no
methodological limitations such as ferromagnetic objects
or narrow scanners that hinder stimulus application.
Furthermore, fNIRS has a high ecological validity and al-
lows an investigation in sitting position, without head
fixation, scanner noise, and anxiety-inducing surround-
ing. So far, fNIRS as well as fMRI do not allow individual
data analysis; both methods are limited to group ana-
lyses. Therefore fNIRS also is not suitable to visualize
pain in the clinical routine of individual patients. Thus,
new approaches are needed to decipher the underlying
mechanisms of pain particularly in complex conditions
like FMS [58]. The major contribution of our explorative
study is that fNIRS as an easy to apply new imaging
technique without side effects is suitable to investigate
pain-associated cortical activity. Furthermore, FMS
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patients show a cortical activation pattern upon painful
stimulation that is distinct from healthy controls and es-
pecially from patients with depression. This strengthens
the notion that FMS is an independent entity rather than
being a mere variant of depression.
Conclusion
The major contribution of our explorative study is that
fNIRS as an easy to apply new imaging technique without
side effects is suitable to investigate pain-associated cortical
activity. Furthermore, FMS patients show a cortical activa-
tion pattern upon painful stimulation that is distinct from
healthy controls and especially from patients with depres-
sion. This strengthens the notion that FMS is an independ-
ent entity rather than being a mere variant of depression.
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